ArticleAACE endocrinology and diabetes
Type 2 Diabetes Mellitus or Maturity Onset Diabetes in the Young Due to Wolfram Syndrome Gene-1 Mutation-A Perplexing Case.
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: Maturity Onset Diabetes in the Young (MODY) is the most common form of monogenic diabetes caused by various single gene mutations. We present a patient with presumed type 2 diabetes mellitus (T2DM), ultimately diagnosed with MODY due to heterozygous Wolfram Syndrome 1 (WFS1) gene mutation. Case Description: Our patient was diagnosed with T2DM at age 22 and treated with oral medications and lifestyle modifications. At age 45, patient's HbA1c was 11.4% (reference <5.7%) on metformin XR 1000 mg twice daily. Additional testing (serum glucose 216 mg/dL [reference: 70-125 mg/dL], C-peptide level 2.18 ng/mL [reference 0.78-5.19 ng/mL], undetectable glutamic acid decarboxylase antibody 65 [GAD-65] [reference: 0.0-5.0 IU/mL], undetectable IgG Islet Cell cytoplasmic antibody [reference: <1:4]) ruled out type 1 diabetes mellitus (T1DM). Due to family history of diabetes and normal body mass index (BMI) 23.2 kg/m Discussion: MODY is a known but uncommon cause of diabetes in young adults. While mutations in HNF1A, GCK, and HNF4A are commonly associated with MODY, rare mutations such as the WFS1 gene mutation should be considered. Our patient's WFS1 mutation (NM_006005.3:c.2026C > T; p.Arg676Cys; heterozygous) has not been reported in literature. Conclusion: Young adults with family history of diabetes and normal BMI should be evaluated for MODY when diagnosed with diabetes. A complete mutation panel for MODY should be done to evaluate for lesser-known mutations such as the WFS1 gene mutation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.